Brainsway Ltd
BRSYF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$427.49M
Close$
$1.86
82.4% downside
Current Fair Value
82.4% downsideOvervalued by 82.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $427.49 Million |
|---|---|
| Enterprise Value | $403.82 Million |
| Earnings per Share | $0.22 |
| Beta | 0.15 |
| Outstanding Shares | 40,252,990 |
Return
| Return on Equity | 13.02% |
|---|---|
| Return on Assets | 8.51% |
| Return on Invested Capital | 5.97% |
Valuation & Multiples
| P/E Ratio | 38.94 |
|---|---|
| PEG | 86.52 |
| Price to Sales | 10.62 |
| Price to Book Ratio | 5.31 |
| Enterprise Value to Revenue | 5.77 |
| Enterprise Value to EBIT | 68.52 |
| Enterprise Value to Net Income | 37 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 10, 2026
EPS
$0.05
Est. $0.09Revenue
$17.81 M
Est. $18.95 MInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Brainsway Ltd.
129 employees
CEO: Christopher von Jako
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the tr...